Skip to main navigation Skip to search Skip to main content

siRNA distribution and alpha-synuclein suppression following 7-day siRNA infusion in the Rhesus substantia nigra

Grants and Contracts Details

StatusFinished
Effective start/end date1/1/12 → 10/31/14

Funding

  • Alnylam Pharmaceuticals Incorporated: $829,831.00